Acetylcholine: Clinical Trials

7 trials of Acetylcholine, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

4 completed, 3 terminated. 7 Phase 2, 2 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 27Completed 4, Terminated 3
Phase 12Completed 1, Terminated 1

Follow Acetylcholine: new trials by email Literature Review of Acetylcholine trials Research Report on Acetylcholine

Trials (filtered) newest first · largest first

All 7 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
HeartPhone Cancer Survivors Trial 2019
HeartPhone app, Acetylcholine, Sodium Nitroprusside - Breast Cancer, Leukemia
Phase 1 / Phase 2TerminatedPenn State University22019-04-232026-02-27
Anemia Study in Chronic Kidney Disease (CKD) : Erythropoiesis Via a Novel Prolyl Hydroxylase Inhibitor (PHI) Daprodustat -Forearm Blood Flow (ASCEND-FBF)
Daprodustat, Darbepoetin alfa, Acetylcholine - Anaemia
Phase 2TerminatedGlaxoSmithKline62019-01-102024-03-27
Niacin to Improve Blood Flow in People With Sickle Cell Disease
Niacin-ER, Placebo, L-NMMA - Sickle Cell Disease
Phase 2CompletedNational Heart, Lung, and Blood Institute (NHLBI)302007-07-242020-09-10
Model System for Transient Forearm Blood Vessel Dysfunction
Limb Ischemia, Acetylcholine - Limb Ischemia, Ischemic Preconditioning
Phase 1 / Phase 2CompletedNational Heart, Lung, and Blood Institute (NHLBI)62007-03-262022-08-09
Endothelial Hyperpolarization in Humans
Tetraethylammonium (TEA), L-NG-monomethyl Arginine (L-NMMA), Bradykinin - Hyperlipidemia
Phase 2TerminatedEmory University1742002-07-012018-08-15
Nitric Oxide to Improve Blood Flow in Sickle Cell Disease
L-NMMA, Acetylcholine - Sickle Cell Anemia
Phase 2CompletedNational Institutes of Health Clinical Center (CC)652001-01-012008-03-04
Study of the Effects of Vitamin C on Patients With Type 2 Diabetes
Acetylcholine - Diabetes Mellitus, Non-Insulin Dependent, Non-Insulin Dependent
Phase 2CompletedNational Center for Complementary and Integrative Health (NCCIH)1501999-01-012008-03-04

Conditions studied

Anemia, Sickle Cell (2)  ·  Anemia (1)  ·  Ascorbic Acid Deficiency (1)  ·  Breast Neoplasms (1)  ·  Diabetes Mellitus, Type 2 (1)  ·  Hyperlipidemias (1)  ·  Insulin Resistance (1)  ·  Leukemia (1)  ·  Lymphoma (1)

Sponsors

National Heart, Lung, and Blood Institute (NHLBI) (2)  ·  Emory University (1)  ·  GlaxoSmithKline (1)  ·  National Center for Complementary and Integrative Health (NCCIH) (1)  ·  National Institutes of Health Clinical Center (CC) (1)  ·  Penn State University (1)

Countries

United States (6)  ·  United Kingdom (1)

Top investigators

Arshed A Quyyumi, MD (1)  ·  John F Tisdale, M.D. (1)

Results publications

PMID 21555712, PMID 24675657, PMID 24925526, PMID 25648989, PMID 36005278

NIH funding

2017 (1), R01HL079115 (1)